CMA investigate care homes for the elderly

The Competition and Markets Authority has recently started a market study into the care homes for the elderly to see how well the market works, and to ensure people are being treated fairly.

Not long ago, the Competition and Markets Authority (CMA) began looking into whether care home providers are treating their residents and representatives in a fair manner. In this study, the CMA is encouraging any interested persons to come forward with any information to help them.
Read More

Unfair funfair for fairgoers! CMA targets Funfair business!

The Competition and Markets Authority (CMA) has recently issued a statement of objections to the Showmen’s Guild of Great Britain, a trade association for the travelling funfair business, for its alleged anti-competitive practices.

The Guild’s 127-year-old carnival rules have allegedly protected their own Guild showmen from competition and reduced the chances for potential new attractions to join fairs. This could potentially limit free choice of millions of fairgoers as well as deprive them of access to improved rides and attractions. This could also hinder the fairgoers value for money as a lack of competition can mean a hike in prices.
Read More

CMA’s investigation into the pharmaceutical industry for its steep price increase

Pharmaceutical companies are being investigated over ‘unacceptable and unethical’ price hikes.

The health department spokesman said that the Competition and Markets Authority (CMA) are carrying out five investigations into the pharmaceutical and health sector.
Read More

Enforcement investigation launched in the secondary ticketing sector

The Office of Fair Trading (the U.K.’s former competition watchdog) launched an investigation into the secondary ticketing market back in 2012. As a result of the investigation, four secondary ticket sellers gave undertakings to the current competition watchdog, the Competition and Markets Authority (CMA).

Now, the CMA has recently launched an enforcement investigation to see whether the sector are complying with consumer protection laws.
Read More

The pharmaceutical industry’s £90 million fine for anti-competitive pricing

Earlier this month, the Competition and Markets Authority (CMA) issued an infringement decision that two companies had breached competition laws.

The CMA found that Pfizer (Ltd and Inc) and Flynn Pharma (Ltd and Holdings) both abused their respective dominant positions by imposing unfair prices for phenytoin sodium capsules that they sold in the U.K. This infringed the Chapter II Prohibition of the Competition Act (CA) and Article 102 of the Treaty on the Functioning of the European Union (TFEU).
Read More

Has DX and First Post merger created a substantial lessening of competition in the market?

The Competition and Markets Authority (CMA) are in the process of deciding whether DX Network Services Ltd (DX) and First Post Ltd (First Post) merger has created a ‘substantial lessening of competition in the market’.
Read More

Offering discounts can amount to breach of competition laws in the Pharmaceutical industry

The Competition and Markets Authority (CMA) opened an investigation in December 2015 for a suspected breach of EU and U.K. competition laws in the pharmaceutical industry.

The CMA are looking at whether an unnamed pharmaceutical company has abused a dominant market position by offering discounts on products, which may have breached Chapter II of the Competition Act (CA), and Article 102 Treaty on the Functioning of the European Union (TFEU).
Read More

Director has been disqualified for five years for infringement of Competition law

This case shows the range of powers of the Competition and Markets Authority (CMA). Recently, the CMA managed to secure the disqualification of a director who breached competition law.

Daniel Aston, a former director of Trod Limited, infringed the Competition Act from March 2011 to July 2015 by making an anti-competitive agreement with GB Eye Limited. The agreement detailed that both companies wouldn’t offer to sell licensed sport and entertainment posters and frames for a lower cost than the other.

This is a clear breach of fair competition rules.
Read More

“A lack of competition in SSCP’s recent acquisition?” – CMA are investigating whether SSCP has acted anti-competitively in Acorn acquisition

In September this year, the Competition Markets Authority (CMA) served an Initial Enforcement Order (IEO) on Stirling Group and SSCP Spring Topco for an allegation that they acted anti-competitively in their recent acquisition.

Earlier this year, Acorn Care 1 Ltd was acquired by SSCP Spring. Acorn is a reputable care service provider who offers special needs education, residential and foster care, for children and young adults with complex needs.

But the acquisition may be in breach of the rules!
Read More

“Suspected anti-competitive agreements in the solid fuel industry” – Agreements that could infringe EU and national competition laws

The Competition and Markets Authority (CMA) are looking into an alleged anti-competition agreement made between companies for the supply of solid fuel products in the U.K.

There are no substantive grounds to find that there has been a breach of national and EU competition laws at present, but the CMA was notified of the suspicions, and an investigation was recently launched.
Read More